Aubagio Slows Grey Matter, Whole Brain Atrophy in CIS, Study Finds

Studied for the first time, Aubagio (teriflunomide) slowed the loss of cortical grey matter and whole-brain volume in people with clinically isolated syndrome (CIS) during two years of therapy, a study found. The treatment was especially effective in those without brain lesions before treatment. Read more…